< 返回主頁

Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3′-digallate (TF3)

by | 4月 7, 2005 | 醫療衛生、設施人手藥物

類型: 連結
出處: Evid Based Complement Alternat Med
連結: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1142193/#__ffn_sectitle